VOA News Examines Conculsion Of MIM Pan-African Malaria Conference
The 5th Multilateral Initiative on Malaria (MIM) Pan-African ConferenceÂ ended Friday inÂ Nairobi, Kenya,Â “ with scientists expressing optimism about several developments in the works to prevent, treat, and possibly eradicate a disease that kills nearly one million people in Africa each year,” VOA News reports.
The experimental malaria vaccine Mosquirix‘s [also known as RTS,S]Â final stage trialsÂ “captured the most attention among the 1,500 scientists at this week’s conference,” the news service writes. ThoughÂ results are “not expected for at least another three years,”Â Christian Loucq, of the PATH Malaria Vaccine Initiative, said,Â “We are definitely excited about it because we have got a certain level of confidence.” He added that researchers are working on building on their findings.
“At this point, we have reached 50 percent efficacy. We need to confirm that and by continuing different types of agents of vaccines, we think we can reach 80 percent in the next decade and a half. There is always a minimum chance that we might not succeed. But at this point in time, we are getting data that do seem to confirm that we have got something,”Â Loucq said.
“Some specialists at the conference presented studies on possible local remedies for the disease …,” according to VOA News. The consensus among scientists is thatÂ a “multi-pronged approach toward eradicating the disease is the best way to cope with a disease that is both adaptable and resilient. They urged international donor[s] to fund not only research into possible vaccines, but other developments that could help human beings stay one step ahead of the parasite.”Â
More than $4 billion is neededÂ per yearÂ to fully combat malaria worldwide, researchersÂ estimate (Ryu, 11/6).Â
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.